ArticleHealth science reports2026
Viscoelastic Testing for Coagulation Management in Vascular Surgery-A Narrative Review.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Viscoelastic testing (VET) has been increasingly used in cardiac, trauma, and hepatic surgery where it helps tackle the development of complex coagulopathies. Despite this, data on using VETs in vascular surgery remains limited to small and non-randomised control studies. Although the improvement in vascular techniques has decreased the rate of massive haemorrhages, there remain situations where they are a serious risk, and the associated coagulopathies pose a challenge to manage. Aims: The aim of this paper is to review the current approved uses of VET and its potential translational benefit in vascular surgery. Methods: An initial PUBMED search provided the foundation for chain sampling to identify relevant papers. Results: With VET, clinicians can rapidly assess a patient's global haemostatic function thus allowing the timely, or pre-emptive, correction of coagulopathies. Using the platelet analysis functions pre-operatively helps guide anaesthetic technique as well as temporary discontinuation of anti-platelet therapy, an almost ubiquitous drug among vascular patients. Intra-operatively, the use of this point-of-care test, along with goal-directed algorithms, reduces the volumes of platelets, fibrinogen, and plasma that are transfused. During recovery, using VET can help distinguish a coagulopathic bleed from one requiring surgical re-exploration. Besides reducing the well-established adverse effects of transfusions, from electrolyte disturbances to the more rare but severe graft-vs-host disease, there is a significant cost-reducing effect. Conclusions: Although there is limited evidence of VET in vascular surgery, there seems to be a clear benefit from its use warranting further large randomised controlled trials from which standardised guidelines can be produced.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.